PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
10-May-2022 GeneCentric to Present Initial Clinicogenomic Results from the GARNER High-Risk Non-Muscle Invasive Bladder Cancer Real-World Study Businesswire
10-May-2022 Rallybio Reports First Quarter 2022 Financial Results Businesswire
10-May-2022 ENDRA Life Sciences Issued Additional U.S. and Chinese Patents for its TAEUS® System Businesswire
10-May-2022 OncoNano Medicine Announces the Appointment of Elina Lavit as Vice President, Business Development Businesswire
10-May-2022 Neogene Therapeutics Announces Approval of Clinical Trial Application for its First Phase 1 Trial of Novel, Fully-Individualized TCR Therapy to Treat Advanced Solid Tumors Businesswire
10-May-2022 Instem Awarded EMA Research Grant Businesswire
10-May-2022 Quanterix Corporation Releases Operating Results for First Quarter 2022 Businesswire
10-May-2022 Imvax to Present at Two Investor Conferences in May Businesswire
10-May-2022 Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Frédéric Matonti, a Leading Ophthalmology Specialist Businesswire
10-May-2022 Teva Publishes 2021 ESG Progress Report, Showcasing Further Integration of ESG Into Business, Robust Targets and Strengthened ESG Governance Structure Businesswire
10-May-2022 Recordati Rare Diseases Announces Multiple Scientific Abstracts to Be Highlighted at American Association of Clinical Endocrinology Businesswire
10-May-2022 Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions to Streamline Biologics Development and Compliance Businesswire
10-May-2022 Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi Businesswire
10-May-2022 Elo Life Systems Appoints Experienced Ag and Lifesciences Executive, Todd Rands, as New Chief Executive Officer Businesswire
10-May-2022 Flora Growth Reports Fiscal Year End 2021 Results Businesswire
10-May-2022 AdaptHealth Reports First Quarter 2022 Results, Updates 2022 Guidance, and Announces $200 Million Share Repurchase Program Businesswire
10-May-2022 MOMA Therapeutics Announces $150 Million Series B Financing Businesswire
10-May-2022 Epizyme Reports First Quarter 2022 Financial Results and Provides Business Update Businesswire
10-May-2022 Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates Businesswire
10-May-2022 Global Superdisintegrants Market Research Report to 2027 - Featuring Anshul Life Sciences, Asahi Kasei and Ashland Global Specialty Chemicals Among Others - ResearchAndMarkets.com Businesswire